Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 125273
Published online Nov 15, 2026. doi: 10.4251/wjgo.125273
Published online Nov 15, 2026. doi: 10.4251/wjgo.125273
Table 1 Gut microbiota and inflammatory bowel disease
| Intestinal Bacteria | Bacterial loaded | Involved or altered metabolic pathway | Associated inflammatory disease | Immuno-modulatory effect | Ref |
| Faecalibacterium prausnitzii | ↓ | Butyrate synthesis. Mucus production promotion | CD; UC | Induces IL10RA-dependent claudin-2 suppression and promotes the differentiation of regulatory T cells | [126] |
| Prevotella (p. Ej. P. Copri) | Depending on the species | Fiber fermenter | ↑ incidence and complications of IBS and IBD | Inhibits the autoimmune response and maintains the intestinal barrier | [127] |
| SCFA | Associated with systemic inflammation, altering the production of cytokines and regulatory T cells | ||||
| Producer (propionate and acetate) | |||||
| Bacteroides fragilis enterotoxigénic | ↑ | Beneficial gut bacteria that feed complex carbohydrates | UC | It disrupts the immune response by promoting or exacerbating inflammation | [128] |
| Toxicogenic strain, pro-inflammatory signaling, and disruption of the intestinal barrier | Active IBD | ||||
| CRC risk | |||||
| Veillonella parvula | ↑ | Lactate-fermenting opportunistic pathogenic commensal bacterium | Active UC | Increases the permeability of epithelial cells in the colon by activating macrophages and producing pro-inflammatory factors | [129] |
| Tyzzerella nexilis | ↑ | Commensal bacterium involved in the fermentation of indigestible carbohydrates and the synthesis SCFA | Intestinal inflammation | Mobile genetic elements confer pathogenic properties and promote neuroinflammation | [130] |
| Rothia mucilaginosa | ↑ | - | IBD | Increases levels of circulating lymphocytes and correlates with the inflammatory marker calprotectin | [131] |
| Blautia hansenii | ↓ in active disease | Synthesis SCFA helps maintain the function of colonic mucus | ↓ in active disease | Prevent the adhesion of pathogenic bacteria | [132] |
| Suppression of pro-inflammatory response | |||||
| Akkermansia muciniphila | ↓ | Degrade the glycoprotein mucin as a source of carbon and nitrogen | IBD | Reduces the levels of infiltrating macrophages in the colon and cytotoxic T cells | [133] |
| Bifidobacterium spp. | ↓ | Fermentation of complex carbohydrates (fiber) | CD; UC | Regulates intestinal inflammation, promotes T-cell response, and strengthens the intestinal barrier | [134] |
| Lactobacillus spp. | ↓ | Lactate synthesis, immune modulators, and intestinal barrier repair | IBD | It regulates cytokine production and reduces the effects of TNF-α. It induces the production of B cells, NK cells, and Treg cells | [135,136] |
| Enterococcus faecalis | ↑ | Biofilm formation, pro-inflammatory cytokines, and glucosamine metabolism | IBD complicated | Pathobiont behavior activates NF-κB and TLR inflammatory pathways | [137] |
- Citation: Delgado-Gonzalez P, Quiroz-Reyes AG, Simental-Mendía MA, Loaiza-Gutiérrez VL, Garza-Treviño EN. Inflammation-driven carcinogenesis in ulcerative colitis: Molecular and immunological pathways. World J Gastrointest Oncol 2026; 18(11): 125273
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/125273.htm
- DOI: https://dx.doi.org/10.4251/wjgo.125273